Skip to content
10-Q

Quarterly Report

SANGAMO THERAPEUTICS, INC SGMO

0001001233-25-000024

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 336.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 304.27M sh
Shares Diluted Q3 2025 · Sep 30, 2025 260.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 214.33M sh
Shares Diluted Q3 2025 · Sep 30, 2024 198.85M sh
Capex Q3 2025 · Sep 30, 2025 $88K
Capex Q3 2025 · Sep 30, 2024 $115K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$72.81M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$63.79M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $29.62M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $41.92M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $39.2M
Cash And Equivalents Q3 2025 · Dec 31, 2023 $45.2M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.24M
Stockholders Equity Q3 2025 · Jun 30, 2025 $19.6M
Stockholders Equity Q3 2025 · Dec 31, 2024 $22.77M
Stockholders Equity Q3 2025 · Sep 30, 2024 $39.13M
Stockholders Equity Q3 2025 · Jun 30, 2024 $23.69M
Stockholders Equity Q3 2025 · Dec 31, 2023 $82.89M
Current Liabilities Q3 2025 · Sep 30, 2025 $50.13M
Current Liabilities Q3 2025 · Dec 31, 2024 $45.81M
Total Liabilities Q3 2025 · Sep 30, 2025 $82.4M
Total Liabilities Q3 2025 · Dec 31, 2024 $78.87M
Current Assets Q3 2025 · Sep 30, 2025 $44.08M
Current Assets Q3 2025 · Dec 31, 2024 $51.69M
Total Assets Q3 2025 · Sep 30, 2025 $88.64M
Total Assets Q3 2025 · Dec 31, 2024 $101.64M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2024 $0.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.37
Eps Basic Q3 2025 · Sep 30, 2025 −$0.11
Eps Basic Q3 2025 · Sep 30, 2025 −$0.33
Eps Basic Q3 2025 · Sep 30, 2024 $0.05
Eps Basic Q3 2025 · Sep 30, 2024 −$0.37
Sga Expense Q3 2025 · Sep 30, 2025 $7.99M
Sga Expense Q3 2025 · Sep 30, 2025 $27.13M
Sga Expense Q3 2025 · Sep 30, 2024 $11.05M
Sga Expense Q3 2025 · Sep 30, 2024 $34.86M
Rd Expense Q3 2025 · Sep 30, 2025 $28.14M
Rd Expense Q3 2025 · Sep 30, 2025 $81.23M
Rd Expense Q3 2025 · Sep 30, 2024 $27.73M
Rd Expense Q3 2025 · Sep 30, 2024 $87.85M
Net Income Q3 2025 · Sep 30, 2025 −$34.93M
Net Income Q3 2025 · Sep 30, 2025 −$85.51M
Net Income Q3 2025 · Sep 30, 2024 $10.67M
Net Income Q3 2025 · Sep 30, 2024 −$74.55M
Operating Income Q3 2025 · Sep 30, 2025 −$35.55M
Operating Income Q3 2025 · Sep 30, 2025 −$83.04M
Operating Income Q3 2025 · Sep 30, 2024 $10.63M
Operating Income Q3 2025 · Sep 30, 2024 −$77.98M
Revenue Q3 2025 · Sep 30, 2025 $581K
Revenue Q3 2025 · Sep 30, 2025 $25.32M
Revenue Q3 2025 · Sep 30, 2024 $49.41M
Revenue Q3 2025 · Sep 30, 2024 $50.25M